m6A modification: recent advances, anticancer targeted drug discovery and beyond

LJ Deng, WQ Deng, SR Fan, MF Chen, M Qi, WY Lyu… - Molecular cancer, 2022 - Springer
Abstract Abnormal N6-methyladenosine (m6A) modification is closely associated with the
occurrence, development, progression and prognosis of cancer, and aberrant m6A …

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions

A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - academic.oup.com
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …

AlphaFold2 protein structure prediction: Implications for drug discovery

N Borkakoti, JM Thornton - Current opinion in structural biology, 2023 - Elsevier
The drug discovery process involves designing compounds to selectively interact with their
targets. The majority of therapeutic targets for low molecular weight (small molecule) drugs …

Opportunities and challenges in application of artificial intelligence in pharmacology

M Kumar, TPN Nguyen, J Kaur, TG Singh, D Soni… - Pharmacological …, 2023 - Springer
Artificial intelligence (AI) is a machine science that can mimic human behaviour like
intelligent analysis of data. AI functions with specialized algorithms and integrates with deep …

The machine learning life cycle and the cloud: implications for drug discovery

O Spjuth, J Frid, A Hellander - Expert opinion on drug discovery, 2021 - Taylor & Francis
Introduction: Artificial intelligence (AI) and machine learning (ML) are increasingly used in
many aspects of drug discovery. Larger data sizes and methods such as Deep Neural …

Artificial intelligence in pharmacology research and practice

M van der Lee, JJ Swen - Clinical and Translational Science, 2023 - Wiley Online Library
In recent years, the use of artificial intelligence (AI) in health care has risen steadily,
including a wide range of applications in the field of pharmacology. AI is now used …

[HTML][HTML] Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery

S Singh, R Kumar, S Payra, SK Singh - Cureus, 2023 - ncbi.nlm.nih.gov
Artificial intelligence (AI) has transformed pharmacological research through machine
learning, deep learning, and natural language processing. These advancements have …

Success stories of AI in drug discovery-where do things stand?

KK Mak, MK Balijepalli, MR Pichika - Expert opinion on drug …, 2022 - Taylor & Francis
Introduction Artificial intelligence (AI) in drug discovery and development (DDD) has gained
more traction in the past few years. Many scientific reviews have already been made …

Chemical toxicity prediction based on semi-supervised learning and graph convolutional neural network

J Chen, YW Si, CW Un, SWI Siu - Journal of cheminformatics, 2021 - Springer
As safety is one of the most important properties of drugs, chemical toxicology prediction has
received increasing attentions in the drug discovery research. Traditionally, researchers rely …

Machine learning-based model for accurate identification of druggable proteins using light extreme gradient boosting

O Alghushairy, F Ali, W Alghamdi, M Khalid… - Journal of …, 2024 - Taylor & Francis
The identification of druggable proteins (DPs) is significant for the development of new
drugs, personalized medicine, understanding of disease mechanisms, drug repurposing …